$300 | Single User
$600 | Site License
$900 | Global License

Summit Therapeutics Plc (SUMM) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

Published by Global Data: 09 Mar 2018 | 196149 | In Stock

Introduction

Summary

Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the infectious disease caused by the bacteria C difficile. It develops ridinilazole, an antibiotic that has the potential to treat CDI and reduce disease recurrence. Summit undertakes utrophin modulation program for duchenne muscular dystrophy. The company also develops novel antibiotic program for the treatment of superbug C. difficile. It operates through other pharmaceutical companies and charity foundations and parent advocacy groups. The company operates through its office located in Cambridge, the US. Summit is headquartered in Abingdon, the UK.

Summit Therapeutics Plc Key Recent Developments

Dec 06,2017: Summit Therapeutics Reports Financial Results for the Third Quarter and Nine Months Ended 31 October 2017 and Operational Progress

Nov 09,2017: Summit Highlights Utrophin Modulation as a Potential Universal Treatment Option in DMD at Action Duchenne

Aug 31,2017: Summit Therapeutics Reports Financial Results For The Second Quarter And Half Year Ended 31 July 2017 And Operational Progress

Jun 14,2017: Summit Therapeutics Reports Financial Results For The First Quarter Ended 30 April 2017 And Operational Progress

May 23,2017: Summit Announces Key Appointments to Strengthen Research & Development Team

This comprehensive SWOT profile of Summit Therapeutics Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Summit Therapeutics Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table of Contents
for Summit Therapeutics Plc (SUMM) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

  • Table of Contents

    Section 1 - About the Company

    Summit Therapeutics Plc - Key Information

    Summit Therapeutics Plc - Overview

    Summit Therapeutics Plc - Key Employees

    Summit Therapeutics Plc - Key Employee Biographies

    Summit Therapeutics Plc - Key Operational Heads

    Summit Therapeutics Plc - Major Products and Services

    Summit Therapeutics Plc - History

    Summit Therapeutics Plc - Company Statement

    Summit Therapeutics Plc - Locations And Subsidiaries

    Summit Therapeutics Plc - Key Manufacturing facilities

    Head Office

    Other Locations & Subsidiaries

    Section 2 - Company Analysis

    Summit Therapeutics Plc - Business Description

    Summit Therapeutics Plc - Corporate Strategy

    Summit Therapeutics Plc - SWOT Analysis

    SWOT Analysis - Overview

    Summit Therapeutics Plc - Strengths

    Summit Therapeutics Plc - Weaknesses

    Summit Therapeutics Plc - Opportunities

    Summit Therapeutics Plc - Threats

    Summit Therapeutics Plc - Key Competitors

    Section 3 - Company Financial Performance Charts

    Summit Therapeutics Plc - Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 - Appendix

    Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

    Note*: Some sections may be missing if data is unavailable for the company

List Of Tables
in Summit Therapeutics Plc (SUMM) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

List of Tables


Summit Therapeutics Plc, Key Information

Summit Therapeutics Plc, Key Ratios

Summit Therapeutics Plc, Share Data

Summit Therapeutics Plc, Major Products and Services

Summit Therapeutics Plc, History

Summit Therapeutics Plc, Key Employees

Summit Therapeutics Plc, Key Employee Biographies

Summit Therapeutics Plc, Key Operational Heads

Summit Therapeutics Plc, Other Locations

Summit Therapeutics Plc, Subsidiaries

Summit Therapeutics Plc, Key Manufacturing facilities

Summit Therapeutics Plc, Key Competitors

Summit Therapeutics Plc, SWOT Analysis

Summit Therapeutics Plc, Ratios based on current share price

Summit Therapeutics Plc, Annual Ratios

Summit Therapeutics Plc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in Summit Therapeutics Plc (SUMM) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018]

List of Figures


Summit Therapeutics Plc, Performance Chart

Summit Therapeutics Plc, Ratio Charts

Additional Details

Publisher

Global Data

Publisher Information

Reference

196149 | GDPH82279FSA

Number of Pages

25

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Summit Therapeutics Plc (SUMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummarySummit Therapeutics Plc (Summit) formerly Summit Corporation Plc is a drug discovery and deve...
24 Feb 2017 by Global Data USD $250 More Info
Summit Therapeutics Plc (SUMM) - Financial and Strategic SWOT Analysis Review
SummarySummit Therapeutics Plc (Summit) formerly Summit Corporation Plc is a drug discovery and deve...
13 Jan 2017 by Global Data USD $300 More Info
Summit Therapeutics Plc (SUMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummarySummit Therapeutics Plc (Summit) formerly Summit Corporation Plc is a drug discovery and deve...
13 Dec 2016 by Global Data USD $250 More Info
Summit Therapeutics Plc (SUMM) - Financial and Strategic SWOT Analysis Review
SummarySummit Therapeutics Plc (Summit) formerly Summit Corporation Plc is a drug discovery and deve...
11 Jul 2016 by Global Data USD $300 More Info
Summit Therapeutics Plc (SUMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummarySummit Therapeutics Plc (Summit) formerly Summit Corporation Plc is a drug discovery and deve...
12 May 2016 by Global Data USD $250 More Info
Summit Therapeutics Plc (SUMM) - Financial and Strategic SWOT Analysis Review
SummarySummit Therapeutics Plc (Summit) formerly Summit Corporation Plc is a drug discovery and deve...
15 Apr 2016 by Global Data USD $300 More Info
Summit Therapeutics plc (formerly Summit Corporation plc) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $350 More Info
Summit Therapeutics Plc (SUMM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummarySummit Therapeutics Plc (Summit) formerly Summit Corporation Plc is a drug discovery and deve...
16 Mar 2016 by Global Data USD $250 More Info
Summit VetPharm, LLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and In...
10 Mar 2016 by Marketline USD $350 More Info
Summit Therapeutics Plc (SUMM) - Financial and Strategic SWOT Analysis Review
SummarySummit Therapeutics plc.(Summit) is a drug discovery and development company. It undertakes d...
09 Jan 2016 by Global Data USD $300 More Info

This report is published by Global Data

Download Free Report Summary PDF

Summit Therapeutics Plc (SUMM) - Financial and Strategic SWOT Analysis Review [Report Updated: 09-03-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data